The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study

BACKGROUND: Although disease-modifying therapies (DMTs) in multiple sclerosis (MS) are known to target the immune system, mechanisms of action, efficacy, safety, and tolerability profiles differ. The long-term impact of DMTs on the immune system and its relation to infectious complications is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Ana, Flaskamp, Martina, Berthele, Achim, Held, Friederike, Muratovic, Harisa, Hemmer, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126592/
https://www.ncbi.nlm.nih.gov/pubmed/37114068
http://dx.doi.org/10.1177/17562864231162661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126592/
https://www.ncbi.nlm.nih.gov/pubmed/37114068
http://dx.doi.org/10.1177/17562864231162661

Ejemplares similares